Christopher K. Murray - 04 Dec 2023 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
CHIEF TECHNICAL OPERATIONS
Signature
/s/ Melissa Masse, Attorney-in-Fact
Issuer symbol
BPMC
Transactions as of
04 Dec 2023
Transactions value $
-$42,858
Form type
4
Date filed
06 Dec 2023, 20:45
Previous filing
30 Oct 2023
Next filing
11 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Sale -$42.9K -600 -2.39% $71.43 24.5K 04 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effected pursuant to a trading plan adopted on June 5, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.